Corrigendum to "Reversal of the deleterious effects of chronic dietary HFCS-55 intake by PPAR- δ agonism correlates with impaired NLRP3 inflammasome activation'' [Biochem. Pharmacol. 85(2) (2013) 257-264]

Biochem Pharmacol. 2024 Mar 1;222:116060. doi: 10.1016/j.bcp.2024.116060. Online ahead of print.NO ABSTRACTPMID:38430671 | DOI:10.1016/j.bcp.2024.116060

Source: Biochemical Pharmacology - March 2, 2024 Category: Drugs & Pharmacology Authors: Massimo Collino Elisa Benetti Mara Rogazzo Raffaella Mastrocola Muhammed M Yaqoob Manuela Aragno Christroph Theimermann Roberto Fantozzi Source Type: research